The integration of all essential probes, instruments, software, and delivery systems for automated delivery of media concentrations of key components can be a daunting task. We have created a default control algorithm and next generation integrated system for CHO cell expression of biologics that can be customized in as little as three optimization runs.
By employing a proprietary self-learning predictive-control algorithm, continuous glucose adjustments are made, resulting in high cell counts, better viability, and improved biologic yield. The technology can speed process development and open new possibilities for control of biopharmaceutical production.
Paul has nearly three decades of experience in market-leading global life-science research supply companies including ThermoFisher, Merck Millipore, and REPROCELL in executive positions of technology management, business development, marketing and sales. He has also held scientific positions at the National Institute of Environmental Health Science (NC, USA) and the Yokohama RIKEN Institute. Currently Paul is employed with Yokogawa Electric Corporation (Tokyo) in global market development for commercialization of new biopharmaceutical engineering production technologies. Having worked in Japan for over 20 years, he is a permanent resident currently residing in Yokohama Japan with his wife and family.
View Webinar